Medicare Enrolled

Dr. Sumit Kumar, M.D.

Nephrology · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
9900 N CENTRAL EXPY STE 215, Dallas, TX 75231
2143964950
In practice since 2006 (20 years)
NPI: 1598743098 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kumar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kumar

Dr. Sumit Kumar is a nephrology in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kumar performed 2,477 Medicare services across 926 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kumar received a total of $158,105 from 47 pharmaceutical and/or device companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kumar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 18% volume in TX$ $158,105 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,477
Medicare services
Top 18% in TX for nephrology
926
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~124 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Remote patient monitoring device, 30 days549$40$127
Remote patient monitoring management, 20 min/month379$39$104
Office visit, established patient, complex (40-54 min)366$106$298
Hospital follow-up visit, moderate complexity267$63$148
Hospital follow-up visit, high complexity199$94$213
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes184$32$85
Office visit, established patient (30-39 min)164$86$222
Dialysis services, 4 or more physician visits per month (20 years or older)149$280$585
Initial hospital admission, high complexity56$132$412
New patient office visit, complex (60-74 min)54$165$423
Telephone medical discussion with physician, 21-30 minutes41$56$355
Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist33$177$2,705
Dialysis services, 2-3 physician visits per month (20 years or older)21$234$492
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment15$16$38
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$158,105
Total received (2018-2024)
Avg $22,586/year across 7 years
Top 2% in TX for nephrology
47
Companies
461
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137,550 (87.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,683 (6.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,872 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$60,851
2023
$4,736
2022
$27,407
2021
$28,537
2020
$5,193
2019
$19,849
2018
$11,533

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Aurinia Pharma U.S., Inc.
$45,059
Horizon Therapeutics plc
$32,279
Boehringer Ingelheim Pharmaceuticals, Inc.
$28,908
Lilly USA, LLC
$18,058
Travere Therapeutics, Inc.
$15,351
Ironwood Pharmaceuticals, Inc
$9,588
La Jolla Pharmaceutical Company
$1,438
AstraZeneca Pharmaceuticals LP
$1,197
Intuitive Surgical, Inc.
$1,190
Janssen Pharmaceuticals, Inc
$424
Amgen Inc.
$381
CorMedix Inc.
$365
Mallinckrodt Hospital Products Inc.
$360
Otsuka America Pharmaceutical, Inc.
$319
Fresenius USA Marketing, Inc.
$276
CALLIDITAS THERAPEUTICS US INC.
$261
OPKO Pharmaceuticals, LLC
$211
Bayer HealthCare Pharmaceuticals Inc.
$198
Ardelyx, Inc.
$194
Horizon Pharma plc
$171
Novartis Pharmaceuticals Corporation
$166
Teleflex LLC
$145
Relypsa, Inc.
$127
GlaxoSmithKline, LLC.
$124
AKEBIA THERAPEUTICS INC
$121
Mallinckrodt Enterprises LLC
$115
GENZYME CORPORATION
$109
Calliditas Therapeutics US Inc.
$103
Outset Medical Inc
$101
Mallinckrodt LLC
$82
Alnylam Pharmaceuticals Inc.
$78
Philips Electronics North America Corporation
$71
Renalytix AI, Inc.
$69
Vifor Pharma, Inc.
$65
Vertex Pharmaceuticals Incorporated
$56
Novo Nordisk Inc
$54
Genentech, Inc.
$52
Shire North American Group Inc
$41
Alexion Pharmaceuticals, Inc.
$38
Keryx Biopharmaceuticals, Inc.
$34
PFIZER INC.
$25
SCPHARMACEUTICALS INC.
$22
Retrophin, Inc.
$21
Medtronic, Inc.
$18
Cumberland Pharmaceuticals, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$13
Ethicon US, LLC
$11
Top 3 companies account for 67.2% of total payments
Associated products mentioned in payments ›
(6582) Visions 035 · (815) Thiola · ACTHAR · AURYXIA · Auryxia · BENLYSTA · CHANTIX · Caldolor · DUZALLO · Da Vinci Surgical System · DefenCath · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · FABRAZYME · FABRY-DISEASE · FARXIGA · FUROSCIX · Fabhalta · GATTEX · GIAPREZA · GUIDELINER · IBSRELA · INVOKANA · JARDIANCE · JYNARQUE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · Korsuva · LINX Reflux Management System · LOKELMA · LUPKYNIS · OXLUMO · Ozempic · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Velphoro · Veltassa · XARELTO · XPHOZAH 30 MG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for nephrology in TX.

Equivalent to $6,383 per 100 Medicare services performed
Looking for a nephrology in Dallas?
Compare nephrologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse nephrologys nearby

Geographic Context

Nephrologys within 10 mi
212
Per 100K population
8.1
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kumar is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kumar experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. Kumar performed 549 remote patient monitoring device, 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumar receive payments from pharmaceutical companies?
Yes. Dr. Kumar received a total of $158,105 from 47 companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumar's costs compare to other nephrologys in Dallas?
Dr. Kumar's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →